STAMBP and vitiligo: Afamelanotide, an α‐MSH analogue, synergistically with NB‐UVB could induce the migration and differentiation of follicular MSCs into epidermal MCs, which has shown promise in the clinical treatment of vitiligo (NCT04525157 and NCT01430195).84, 85, 86